Travere Therapeutics Corporate Overview February 2026 Forward-Looking Statements This presentation contains forward-looking statements, including but not limited to statements about: continued progress with the FILSPARI launch in IgAN; statements regarding our products and products in development as potential foundational treatments and/or treatment standards; additional development and regulatory milestones, including expected data from additional studies and the expected timing thereof; plans and expectat ...

Forward-Looking Statements This presentation (and oral statements relating to this presentation) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical facts, that express or involve discussions of expectations, beliefs, plans, objectives, outlooks, assumptions, or future events or performance are forward-looking. Forward-looking statements are not guarantees of future performance, involve estimates, ...

Prothena Fourth Quarter and Year-End 2025 Financial Results 4Q and FY25 Earnings Call Agenda | Welcome | Mark Johnson Vice President, Head of Investor Relations | | --- | --- | | Opening Remarks | Gene Kinney, Ph.D. President and CEO | | Clinical Programs | Chad Swanson, Ph.D. Chief Development Officer | | Preclinical Programs | Philip Dolan, Ph.D. Vice President, Head of Discovery Research | | Financial Results | Tran Nguyen Chief Strategy Officer and Chief Financial Officer | | Closing Remarks | Gene Kinn ...

February 2026 Investor Presentation Forward-looking statements disclaimer This presentation contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward- looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts contained in this presentation may be forward-looking statements. In some cases, you can identify ...

iRhythm Holdings Fourth Quarter 2025 Results February 19, 2026 © 2026 iRhythm Holdings, Inc. 1 Cautionary statement re forward-looking statements, non-GAAP measures and other matters Certain data in this presentation was obtained from various external sources, and neither "iRhythm Holdings, Inc. ("iRhythm" or the "Company") nor its affiliates, advisers or representatives has verified such data with independent sources. Accordingly, neither the Company nor any of its affiliates, advisers or representatives m ...

ICU Medical Q4 2025 Conference Call Presentation February 19, 2026 1 Disclosures 2 > Any statement concerning Management's expectation with respect to future results is a forward-looking statement based upon the best information currently available to Management and assumptions Management believes are reasonable, but Management does not intend the statement to be a representation as to future results. > Future results are subject to risks and uncertainties, including the risk factors described in the Compan ...

IT'S AN WORLD AFTER ALL CHAIRMAN & CHIEF EXECUTIVE OFFICER TARANG AMIN As a reminder, this presentation contains forward-looking statements that are based on management's expectations – including those relating to the category trends and longer-term outlook – and are subject to known and unknown risks and uncertainties, and therefore, actual results may differ materially. Important factors that may cause actual results to differ are detailed in the company's SEC filings. In addition, the company's presentat ...

2025 Earnings Release Presentation February 19, 2026 Investor Relations Available Information On February 19, 2026, Consolidated Edison, Inc. issued a press release reporting its 2025 earnings and filed with the Securities and Exchange Commission the company's 2025 Form 10-K. This presentation should be read together with, and is qualified in its entirety by reference to, the earnings press release and the Form 10-K. Copies of the earnings press release and the Form 10-K are available at: www.conedison.com/ ...

Consumer Analyst Group of New York (CAGNY) Conference February 19, 2026 Disclaimer Page Cautionary Statements Regarding Forward-Looking Information This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, forecasted financial performance or guidance, statements about future results of operations and other statements which are not purely historical facts or that necessarily d ...

Financial Results Call Presentation Fourth Quarter and Full Year 2025 February 19, 2026 NYSE: AWR Today's Presenters Robert J. Sprowls President & CEO Eva G. Tang SVP – Finance & CFO This conference call includes a discussion of certain measures that are not prepared in accordance with Generally Accepted Accounting Principles ("GAAP") in the United States, and constitute "non-GAAP financial measures" under SEC rules. These non-GAAP financial measures are derived from consolidated financial information but a ...